| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.4 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |